Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 224 items for :

  • ovarian neoplasms x
  • Refine by access: All content x
Clear All
M Wijnen Department of Pediatric Oncology/Hematology, Erasmus MC – Sophia Children’s Hospital, Rotterdam, the Netherlands
Department of Medicine, Section Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands

Search for other papers by M Wijnen in
Google Scholar
PubMed Close
,
M M van den Heuvel-Eibrink Department of Pediatric Oncology/Hematology, Erasmus MC – Sophia Children’s Hospital, Rotterdam, the Netherlands
Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands

Search for other papers by M M van den Heuvel-Eibrink in
Google Scholar
PubMed Close
,
M Medici Department of Medicine, Section Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands
Rotterdam Thyroid Center, Erasmus University Medical Center, Rotterdam, the Netherlands

Search for other papers by M Medici in
Google Scholar
PubMed Close
,
R P Peeters Department of Medicine, Section Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands
Rotterdam Thyroid Center, Erasmus University Medical Center, Rotterdam, the Netherlands

Search for other papers by R P Peeters in
Google Scholar
PubMed Close
,
A J van der Lely Department of Medicine, Section Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands

Search for other papers by A J van der Lely in
Google Scholar
PubMed Close
, and
S J C M M Neggers Department of Pediatric Oncology/Hematology, Erasmus MC – Sophia Children’s Hospital, Rotterdam, the Netherlands
Department of Medicine, Section Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands

Search for other papers by S J C M M Neggers in
Google Scholar
PubMed Close

use objective methods to collect data on secondary malignant neoplasms. Although several studies reported a protective effect of gonadotoxic therapies and premature ovarian insufficiency on radiation-induced breast cancer ( Travis et al . 2003

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-16-0113
Volume/Issue:
Volume 23: Issue 6
Free access
Anna Angelousi Endocrine Unit, 1st Department of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Anna Angelousi in
Google Scholar
PubMed Close
,
Eva Kassi Endocrine Unit, 1st Department of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Eva Kassi in
Google Scholar
PubMed Close
,
Narjes Ansari-Nasiri Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Narjes Ansari-Nasiri in
Google Scholar
PubMed Close
,
Harpal Randeva Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

Search for other papers by Harpal Randeva in
Google Scholar
PubMed Close
,
Gregory Kaltsas Endocrine Unit, 1st Department of Propaedeutic Medicine, Laiko University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed Close
, and
George Chrousos First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by George Chrousos in
Google Scholar
PubMed Close

association of clock genes and endocrine neoplasms. Methods To identify studies and determine eligibility a systematic search was conducted in the PubMed, MEDLINE and Cochrane databases. The search terms included the following: ‘clock genes

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-19-0094
Volume/Issue:
Volume 26: Issue 6
Free access
Angel Chao Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan

Search for other papers by Angel Chao in
Google Scholar
PubMed Close
,
Huei-Jean Huang Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan

Search for other papers by Huei-Jean Huang in
Google Scholar
PubMed Close
,
Chiao-Yun Lin Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan

Search for other papers by Chiao-Yun Lin in
Google Scholar
PubMed Close
,
Chia-Hwa Lee Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan

Search for other papers by Chia-Hwa Lee in
Google Scholar
PubMed Close
,
Chien-Hsing Lin Taiwan Genomic Industry Alliance Inc., Taipei, Taiwan

Search for other papers by Chien-Hsing Lin in
Google Scholar
PubMed Close
,
An-Shine Chao Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Department of Obstetrics and Gynecology, New Taipei Municipal Tu Cheng Hospital, New Taipei City, Taiwan

Search for other papers by An-Shine Chao in
Google Scholar
PubMed Close
,
Chyong-Huey Lai Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan

Search for other papers by Chyong-Huey Lai in
Google Scholar
PubMed Close
,
Ting-Chang Chang Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan

Search for other papers by Ting-Chang Chang in
Google Scholar
PubMed Close
,
Kai-Yun Wu Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan

Search for other papers by Kai-Yun Wu in
Google Scholar
PubMed Close
, and
Ren-Chin Wu Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Department of Anatomic Pathology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan

Search for other papers by Ren-Chin Wu in
Google Scholar
PubMed Close

). Collectively, these data suggest that a hypoxia-derived gene signature can be a relevant hallmark in SCT-NOS. Tumorigenic signals in this rare ovarian neoplasm may therefore act through multiple parallel pathways to activate the transcription factor HIF1α and

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-23-0179
Volume/Issue:
Volume 30: Issue 11
Restricted access
G Scambia Department of Gynaecology/Obstetrics, Catholic University of the Sacred Heart, Rome, Italy

Search for other papers by G Scambia in
Google Scholar
PubMed Close
,
G Ferrandina Department of Gynaecology/Obstetrics, Catholic University of the Sacred Heart, Rome, Italy

Search for other papers by G Ferrandina in
Google Scholar
PubMed Close
,
G D'Agostino Department of Gynaecology/Obstetrics, Catholic University of the Sacred Heart, Rome, Italy

Search for other papers by G D'Agostino in
Google Scholar
PubMed Close
,
A Fagotti Department of Gynaecology/Obstetrics, Catholic University of the Sacred Heart, Rome, Italy

Search for other papers by A Fagotti in
Google Scholar
PubMed Close
,
M Di Stefano Department of Gynaecology/Obstetrics, Catholic University of the Sacred Heart, Rome, Italy

Search for other papers by M Di Stefano in
Google Scholar
PubMed Close
,
F Fanfani Department of Gynaecology/Obstetrics, Catholic University of the Sacred Heart, Rome, Italy

Search for other papers by F Fanfani in
Google Scholar
PubMed Close
,
F G Serri Department of Gynaecology/Obstetrics, Catholic University of the Sacred Heart, Rome, Italy

Search for other papers by F G Serri in
Google Scholar
PubMed Close
, and
S Mancuso Department of Gynaecology/Obstetrics, Catholic University of the Sacred Heart, Rome, Italy

Search for other papers by S Mancuso in
Google Scholar
PubMed Close

Ovarian cancer accounts for 5% of all cancer deaths in Western countries and is the most frequent cause of gynaecologic cancer mortality. The incidence varies with age between 1% and 14% with a peak rate in the eighth decade, and in the majority of cases, the disease has already spread beyond the pelvic cavity at time of diagnosis. Although in the last decades the introduction of cisplatin-based chemotherapy resulted in an improvement of patient survival, the percentage of recurrent disease is high even in those patients who achieve a complete response to chemotherapy, so that more than 80% of patients with advanced stage of disease die within 5 years (Copeland & Gershenson 1986). At present the prognostic characterisation of ovarian cancer patients, based on clinico-pathological parameters, such as stage, histology, grade and residual tumour after surgery, seems to be inadequate, since patients with similar clinico- pathological characteristics often experienced different clinical outcome. Therefore, the identification of biological factors related to tumour aggressiveness could be relevant in order to identify patients with different prognosis and chance to respond to chemotherapy, thus allowing the selection, at time of initial diagnosis, of high risk patients needing more aggressive therapy or alternative treatment, and a closer follow-up. Among the biological parameters proposed as possible prognostic factors in ovarian cancer much attention has been focused on endocrine factors and especially on steroid hormones and their receptors. Although several epidemiological and in vitro evidences have demonstrated that, similarly to breast and endometrial cancer, ovarian cancer cell biology could be influenced by the biochemical pathways promoted by the interaction of estrogens and progesterone with their specific receptors (ER, PR) conflicting data have been reported about the possible clinical role of ER and PR in this neoplasm. This review is aimed: a) to summarise the informations about the influence of steroid hormones and their receptors in the biology of ovarian cancer in in vitro models as well as in primary tumours;b) to investigate the association of steroid hormone receptor expression with the clinico-pathological parameters and the clinical outcome in ovarian cancer patients.c) to report the data of the literature about the rationale and the results of endocrine therapy in ovarian cancer.

Article Type:
Research Article
Volume/Issue:
Volume 5: Issue 4
Free access
M C F Mulders Department of Internal Medicine, ENETS Center of Excellence, Section of Endocrinology, Erasmus Medical Center and Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Search for other papers by M C F Mulders in
Google Scholar
PubMed Close
,
Q G de Lussanet de la Sablonière Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by Q G de Lussanet de la Sablonière in
Google Scholar
PubMed Close
,
M L F van Velthuysen Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by M L F van Velthuysen in
Google Scholar
PubMed Close
,
E M Roes Department of Gynecologic Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Search for other papers by E M Roes in
Google Scholar
PubMed Close
,
J Hofland Department of Internal Medicine, ENETS Center of Excellence, Section of Endocrinology, Erasmus Medical Center and Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Search for other papers by J Hofland in
Google Scholar
PubMed Close
, and
W W de Herder Department of Internal Medicine, ENETS Center of Excellence, Section of Endocrinology, Erasmus Medical Center and Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Search for other papers by W W de Herder in
Google Scholar
PubMed Close

Introduction Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms that predominantly arise from neuroendocrine cells of the embryonic gut and are subdivided into foregut, midgut and hindgut NETs ( Hofland et al. 2020 ). NET

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-23-0035
Volume/Issue:
Volume 30: Issue 8
Restricted access
Helen Gharwan National Cancer Institute, Women's Malignancies Branch, Department of Gynecologic Oncology, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Maryland 20892-1906, USA

Search for other papers by Helen Gharwan in
Google Scholar
PubMed Close
,
Kristen P Bunch National Cancer Institute, Women's Malignancies Branch, Department of Gynecologic Oncology, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Maryland 20892-1906, USA
National Cancer Institute, Women's Malignancies Branch, Department of Gynecologic Oncology, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Maryland 20892-1906, USA

Search for other papers by Kristen P Bunch in
Google Scholar
PubMed Close
, and
Christina M Annunziata National Cancer Institute, Women's Malignancies Branch, Department of Gynecologic Oncology, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Maryland 20892-1906, USA

Search for other papers by Christina M Annunziata in
Google Scholar
PubMed Close

Introduction Ovarian cancer is the fifth leading cause of cancer-related deaths among women and the gynecologic malignancy with the highest mortality rate in the USA ( http://seer.cancer.gov/statfacts/html/ovary.html ; accessed May 2015). Diagnosis

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-14-0550
Volume/Issue:
Volume 22: Issue 6
Free access
Jung-Hye Choi Department of Obstetrics and Gynecology, British Columbia Children’s and Women’s Hospital, Child and Family Research Institute, University of British Columbia, 2H-30, 4490 Oak St, Vancouver, British Columbia, Canada, V6H 3V5

Search for other papers by Jung-Hye Choi in
Google Scholar
PubMed Close
,
Kyung-Chul Choi Department of Obstetrics and Gynecology, British Columbia Children’s and Women’s Hospital, Child and Family Research Institute, University of British Columbia, 2H-30, 4490 Oak St, Vancouver, British Columbia, Canada, V6H 3V5

Search for other papers by Kyung-Chul Choi in
Google Scholar
PubMed Close
,
Nelly Auersperg Department of Obstetrics and Gynecology, British Columbia Children’s and Women’s Hospital, Child and Family Research Institute, University of British Columbia, 2H-30, 4490 Oak St, Vancouver, British Columbia, Canada, V6H 3V5

Search for other papers by Nelly Auersperg in
Google Scholar
PubMed Close
, and
Peter C K Leung Department of Obstetrics and Gynecology, British Columbia Children’s and Women’s Hospital, Child and Family Research Institute, University of British Columbia, 2H-30, 4490 Oak St, Vancouver, British Columbia, Canada, V6H 3V5

Search for other papers by Peter C K Leung in
Google Scholar
PubMed Close

gonadotropin and activin receptor messenger ribonucleic acid in human ovarian epithelial neoplasms. Clinical Cancer Research 6 2764 –2770. Miyazaki M , Nagy A, Schally AV, Lamharzi N, Halmos G, Szepeshazi K, Groot K & Armatis P

Article Type:
Research Article
DOI:
https://doi.org/10.1677/erc.1.01057
Volume/Issue:
Volume 13: Issue 2
Free access
Catherine M Olsen Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia

Search for other papers by Catherine M Olsen in
Google Scholar
PubMed Close
,
Adèle C Green Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia

Search for other papers by Adèle C Green in
Google Scholar
PubMed Close
,
Christina M Nagle Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia

Search for other papers by Christina M Nagle in
Google Scholar
PubMed Close
,
Susan J Jordan Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia
Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia

Search for other papers by Susan J Jordan in
Google Scholar
PubMed Close
,
David C Whiteman Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia

Search for other papers by David C Whiteman in
Google Scholar
PubMed Close
,
Christopher J Bain Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia

Search for other papers by Christopher J Bain in
Google Scholar
PubMed Close
,
Penelope M Webb Cancer and Population Studies Group, School of Population Health, Queensland Institute of Medical Research, Brisbane, 4029, Australia

Search for other papers by Penelope M Webb in
Google Scholar
PubMed Close
, and
on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group
Search for other papers by on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group in
Google Scholar
PubMed Close

Introduction In 1998, Risch (1998) put forward a hypothesis for the pathogenesis of ovarian cancer relating to the role of androgens in stimulating epithelial cell proliferation. Although widely discussed in the aetiologic literature, there is a

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-08-0075
Volume/Issue:
Volume 15: Issue 4
Free access
Jung-Hye Choi Department of Obstetrics and Gynecology, British Columbia Children’s and Women’s Hospital, British Columbia Research Institute for Children’s and Women’s Health, University of British Columbia, Vancouver, British Columbia, Canada V6H 3V5

Search for other papers by Jung-Hye Choi in
Google Scholar
PubMed Close
,
Kyung-Chul Choi Department of Obstetrics and Gynecology, British Columbia Children’s and Women’s Hospital, British Columbia Research Institute for Children’s and Women’s Health, University of British Columbia, Vancouver, British Columbia, Canada V6H 3V5

Search for other papers by Kyung-Chul Choi in
Google Scholar
PubMed Close
,
Nelly Auersperg Department of Obstetrics and Gynecology, British Columbia Children’s and Women’s Hospital, British Columbia Research Institute for Children’s and Women’s Health, University of British Columbia, Vancouver, British Columbia, Canada V6H 3V5

Search for other papers by Nelly Auersperg in
Google Scholar
PubMed Close
, and
Peter C K Leung Department of Obstetrics and Gynecology, British Columbia Children’s and Women’s Hospital, British Columbia Research Institute for Children’s and Women’s Health, University of British Columbia, Vancouver, British Columbia, Canada V6H 3V5

Search for other papers by Peter C K Leung in
Google Scholar
PubMed Close

. Minegishi T , Kameda T, Hirakawa T, Abe K, Tano M & Ibuki Y 2000 Expression of gonadotropin and activin receptor messenger ribonucleic acid in human ovarian epithelial neoplasms. Clinical Cancer Research 6 2764 –2770

Article Type:
Research Article
DOI:
https://doi.org/10.1677/erc.1.00896
Volume/Issue:
Volume 12: Issue 2
Free access
Ying-Cheng Chiang Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan
Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

Search for other papers by Ying-Cheng Chiang in
Google Scholar
PubMed Close
,
Ming-Cheng Chang Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan
Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

Search for other papers by Ming-Cheng Chang in
Google Scholar
PubMed Close
,
Pao-Jen Chen Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

Search for other papers by Pao-Jen Chen in
Google Scholar
PubMed Close
,
Meei-Maan Wu Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan
Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

Search for other papers by Meei-Maan Wu in
Google Scholar
PubMed Close
,
Chang-Yao Hsieh Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

Search for other papers by Chang-Yao Hsieh in
Google Scholar
PubMed Close
,
Wen-Fang Cheng Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan
Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan
Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

Search for other papers by Wen-Fang Cheng in
Google Scholar
PubMed Close
, and
Chi-An Chen Department of Obstetrics and Gynecology, Graduate Institute of Clinical Medicine, Department of Anesthesiology, Department of Obstetrics and Gynecology, Genomics Research Center, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

Search for other papers by Chi-An Chen in
Google Scholar
PubMed Close

PB Saboorian MH Ashfaq R Toyooka KO Toyooka S Minna JD Gazdar AF Schorge JO 2005 Promoter hypermethylation profile of ovarian epithelial neoplasms . Clinical Cancer Research 11 5365 – 5369 . ( doi:10.1158/1078-0432.CCR-04

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0117
Volume/Issue:
Volume 20: Issue 2
Free access